Literature DB >> 2729162

Intestinal glucose and amino acid absorption in healthy volunteers and noninsulin-dependent diabetic subjects.

M C Gulliford1, E J Bicknell, G G Pover, J H Scarpello.   

Abstract

Reducing the rate of glucose absorption is a useful approach to the treatment of noninsulin-dependent diabetes mellitus (NIDDM). Intestinal absorption of glucose and amino acids is known to be increased in diabetes in laboratory animals but has not been systematically studied in human NIDDM subjects. In this study the intestinal absorption of glucose and glycine was measured during steady-state perfusion of the jejunum in 10 NIDDM subjects and in 11 healthy volunteers. Absorption rates were linearly related to solute load for both glucose and glycine. Over the range of solute concentrations, absorption rates of glucose (F = 4.38, p less than 0.05) and glycine (F = 7.07, p less than 0.02) were slightly reduced in diabetic subjects. The reduction in absorption rates may be accounted for by differences in age and diet between the groups. It is concluded that glucose and amino acid absorption is not increased in human NIDDM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729162     DOI: 10.1093/ajcn/49.6.1247

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

Review 1.  Upper gastrointestinal function and glycemic control in diabetes mellitus.

Authors:  Reawika Chaikomin; Christopher K Rayner; Karen-L Jones; Michael Horowitz
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

2.  Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance test.

Authors:  Christian Anderwald; Andrea Tura; Yvonne Winhofer; Michael Krebs; Christine Winzer; Martin G Bischof; Anton Luger; Giovanni Pacini; Alexandra Kautzky-Willer
Journal:  Diabetes Care       Date:  2011-05-20       Impact factor: 19.112

3.  Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs.

Authors:  Kristine Færch; Giovanni Pacini; John J Nolan; Torben Hansen; Andrea Tura; Dorte Vistisen
Journal:  Diabetes Care       Date:  2013-09-23       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.